Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124639035 | 12463903 | 5 | F | 20160601 | 20160629 | 20160614 | 20160705 | EXP | CA-AMGEN-CANSP2016074503 | AMGEN | 58.00 | YR | A | M | Y | 0.00000 | 20160705 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124639035 | 12463903 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | UNK | 103795 | UNKNOWN FORMULATION | |||||||||
| 124639035 | 12463903 | 2 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Unknown | UNK | 0 | ||||||||||
| 124639035 | 12463903 | 3 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | UNK | 0 | ||||||||||
| 124639035 | 12463903 | 4 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 124639035 | 12463903 | 5 | SS | GOLD | GOLD | 1 | Unknown | UNK | 0 | ||||||||||
| 124639035 | 12463903 | 6 | SS | ORENCIA | ABATACEPT | 1 | Unknown | UNK | 0 | ||||||||||
| 124639035 | 12463903 | 7 | SS | REMICADE | INFLIXIMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 124639035 | 12463903 | 8 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 124639035 | 12463903 | 9 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | UNK | 0 | ||||||||||
| 124639035 | 12463903 | 10 | C | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, BID | 0 | 5 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124639035 | 12463903 | 1 | Rheumatoid arthritis |
| 124639035 | 12463903 | 2 | Product used for unknown indication |
| 124639035 | 12463903 | 3 | Product used for unknown indication |
| 124639035 | 12463903 | 4 | Product used for unknown indication |
| 124639035 | 12463903 | 5 | Product used for unknown indication |
| 124639035 | 12463903 | 6 | Product used for unknown indication |
| 124639035 | 12463903 | 7 | Product used for unknown indication |
| 124639035 | 12463903 | 8 | Product used for unknown indication |
| 124639035 | 12463903 | 9 | Rheumatoid arthritis |
| 124639035 | 12463903 | 10 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124639035 | 12463903 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124639035 | 12463903 | Arthralgia | |
| 124639035 | 12463903 | Arthropathy | |
| 124639035 | 12463903 | Bone erosion | |
| 124639035 | 12463903 | Diabetes mellitus | |
| 124639035 | 12463903 | Drug ineffective | |
| 124639035 | 12463903 | Erythema | |
| 124639035 | 12463903 | Hypersensitivity | |
| 124639035 | 12463903 | Ill-defined disorder | |
| 124639035 | 12463903 | Joint swelling | |
| 124639035 | 12463903 | Laceration | |
| 124639035 | 12463903 | Peripheral swelling | |
| 124639035 | 12463903 | Red blood cell sedimentation rate abnormal | |
| 124639035 | 12463903 | Rheumatoid factor negative | |
| 124639035 | 12463903 | Skin ulcer | |
| 124639035 | 12463903 | Swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124639035 | 12463903 | 8 | 2013 | 0 | ||
| 124639035 | 12463903 | 10 | 20160624 | 0 |